Multi-event October 2021 FDA Recall Drug by Vita Pharmacy, Llc Dba Talon Compounding Pharmacy

This Multi-event Class II drug recall was voluntarily initiated by Vita Pharmacy, Llc Dba Talon Compounding Pharmacy on October 12, 2021 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed in United States including Washington, D.C. and Puerto Rico and the recall is currently terminated.

Reported Recall Events

D-0104-2022 TERMINATED D-0179-2022 TERMINATED D-0170-2022 TERMINATED D-0162-2022 TERMINATED D-0198-2022 TERMINATED D-0109-2022 TERMINATED D-0156-2022 TERMINATED D-0130-2022 TERMINATED D-0146-2022 TERMINATED D-0178-2022 TERMINATED D-0224-2022 TERMINATED D-0215-2022 TERMINATED D-0149-2022 TERMINATED D-0169-2022 TERMINATED D-0157-2022 TERMINATED D-0190-2022 TERMINATED D-0131-2022 TERMINATED D-0218-2022 TERMINATED D-0193-2022 TERMINATED D-0158-2022 TERMINATED D-0222-2022 TERMINATED D-0187-2022 TERMINATED D-0101-2022 TERMINATED D-0106-2022 TERMINATED D-0118-2022 TERMINATED D-0098-2022 TERMINATED D-0184-2022 TERMINATED D-0152-2022 TERMINATED D-0139-2022 TERMINATED D-0111-2022 TERMINATED D-0150-2022 TERMINATED D-0196-2022 TERMINATED D-0128-2022 TERMINATED D-0105-2022 TERMINATED D-0188-2022 TERMINATED D-0189-2022 TERMINATED D-0151-2022 TERMINATED D-0223-2022 TERMINATED D-0192-2022 TERMINATED D-0216-2022 TERMINATED D-0136-2022 TERMINATED D-0108-2022 TERMINATED D-0209-2022 TERMINATED D-0182-2022 TERMINATED D-0183-2022 TERMINATED D-0172-2022 TERMINATED D-0163-2022 TERMINATED D-0137-2022 TERMINATED D-0141-2022 TERMINATED D-0185-2022 TERMINATED D-0165-2022 TERMINATED D-0195-2022 TERMINATED D-0164-2022 TERMINATED D-0167-2022 TERMINATED D-0212-2022 TERMINATED D-0180-2022 TERMINATED D-0119-2022 TERMINATED D-0140-2022 TERMINATED D-0134-2022 TERMINATED D-0138-2022 TERMINATED D-0221-2022 TERMINATED D-0176-2022 TERMINATED D-0177-2022 TERMINATED D-0123-2022 TERMINATED D-0219-2022 TERMINATED D-0168-2022 TERMINATED D-0147-2022 TERMINATED D-0159-2022 TERMINATED D-0132-2022 TERMINATED D-0100-2022 TERMINATED D-0200-2022 TERMINATED D-0110-2022 TERMINATED D-0129-2022 TERMINATED D-0220-2022 TERMINATED D-0143-2022 TERMINATED D-0161-2022 TERMINATED D-0102-2022 TERMINATED D-0103-2022 TERMINATED D-0204-2022 TERMINATED D-0133-2022 TERMINATED D-0113-2022 TERMINATED D-0203-2022 TERMINATED D-0197-2022 TERMINATED D-0120-2022 TERMINATED D-0145-2022 TERMINATED D-0225-2022 TERMINATED D-0160-2022 TERMINATED D-0135-2022 TERMINATED D-0115-2022 TERMINATED D-0122-2022 TERMINATED D-0217-2022 TERMINATED D-0213-2022 TERMINATED D-0206-2022 TERMINATED D-0166-2022 TERMINATED D-0127-2022 TERMINATED D-0116-2022 TERMINATED D-0144-2022 TERMINATED D-0226-2022 TERMINATED D-0210-2022 TERMINATED D-0117-2022 TERMINATED D-0171-2022 TERMINATED D-0153-2022 TERMINATED D-0201-2022 TERMINATED D-0211-2022 TERMINATED D-0097-2022 TERMINATED D-0207-2022 TERMINATED D-0155-2022 TERMINATED D-0114-2022 TERMINATED D-0174-2022 TERMINATED D-0199-2022 TERMINATED D-0124-2022 TERMINATED D-0186-2022 TERMINATED D-0125-2022 TERMINATED D-0112-2022 TERMINATED D-0148-2022 TERMINATED D-0191-2022 TERMINATED D-0175-2022 TERMINATED D-0142-2022 TERMINATED D-0202-2022 TERMINATED D-0107-2022 TERMINATED D-0194-2022 TERMINATED D-0099-2022 TERMINATED D-0154-2022 TERMINATED D-0173-2022 TERMINATED D-0214-2022 TERMINATED D-0121-2022 TERMINATED D-0181-2022 TERMINATED D-0205-2022 TERMINATED D-0208-2022 TERMINATED D-0126-2022 TERMINATED

Recall Number: D-0104-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ALPROSTADIL 40MCG/ML INJ 40MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06242021:37 BUD: 10/22/2021; 08132021:74 BUD: 12/11/2021; 07132021:94 BUD:10/23/2021

Recall Number: D-0179-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1229 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1007302021:72 BUD: 01/26/2022; T1005182021:09 BUD: 11/15/2021; T1008112021:73 BUD: 02/07/2022; T1004092021:40 BUD: 10/09/2021; T1006182021:37 BUD: 12/15/2021; T1005242021:71 BUD: 11/20/2021; T1006072021:06 BUD: 12/04/2021; T0606222021:35 BUD: 12/19/2021; T0605112021:23 BUD:11/07/2021 ; T0608162021:19 BUD: 02/12/2022; T1009132021:25 BUD: 03/12/2022; T1004272021:41 BUD: 10/24/2021; T0604152021:26 BUD: 10/12/2021; T1006302021:53 BUD: 12/27/2021; T1008022021:01 BUD: 01/29/2022; T1008302021:73 BUD: 02/26/2022; T1008052021:84 BUD: 02/01/2022; T1007152021:72 BUD: 01/11/2022; T1005112021:54 BUD: 11/07/2021; T1008042021:66 BUD: 01/31/2022; T1007062021:95 BUD: 01/02/2022; T1008302021:73 BUD: 02/26/2022; T1008052021:84 BUD: 02/01/2022; T1007152021:72 BUD: 01/11/2022; T1005112021:54 BUD: 11/07/2021; T1006142021:21 BUD: 12/11/2021; T1008042021:66 BUD: 01/31/2022; T1005102021:94 BUD: 11/06/2021; T1007282021:89 BUD: 01/24/2022; T1009222021:75 BUD: 03/21/2022; T1005052021:79 BUD: 11/01/2021; T1008192021:65 BUD: 02/15/2022; T1007132021:14 BUD: 01/09/2022; T1008162021:35 BUD: 02/12/2022; T0607282021:28 BUD: 01/24/2022; T1006022021:06 BUD: 11/29/2021; T1006222021:31 BUD: 12/19/2021; T1004292021:70 BUD: 10/26/2021; T1007212021:82 BUD: 01/17/2022; T1006282021:88 BUD: 12/25/2021; T1004222021:18 BUD: 10/19/2021; T1009082021:11 BUD: 03/07/2022; T1007082021:50 BUD: 01/04/2022; T1009212021:76 BUD: 03/20/2022; T1008312021:01 BUD: 02/27/2022; T0507062021:21 BUD: 01/02/2022; T1004152021:11 BUD: 10/12/2021; T1004192021:50 BUD: 10/16/2021; T1005132021:31 BUD: 11/09/2021; T1008252021:57 BUD: 02/21/2022; T1009152021:06 BUD: 03/14/2022; T1007232021:57 BUD: 01/19/2022; T1006162021:17 BUD: 12/13/2021; T1007122021:16 BUD: 01/08/2022; T1006102021:50 BUD: 12/07/2021; T1005282021:72 BUD: 11/24/2021; T0209082021:89 BUD: 03/08/2022; T0106092021:28 BUD: 11/07/2021; T0205112021:63 BUD: 11/07/2021; T0604152021:26 BUD: 10/12/2021; T0106092021:53 BUD: 11/07/2021; T0205112021:63 BUD: 11/07/2021; T0209092021:89 BUD: 03/08/2022; T0109032021:43 BUD: 11/07/2021

Recall Number: D-0170-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.25MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1006092021:18 BUD: 12/06/2021; T1009022021:89 BUD: 03/01/2022

Recall Number: D-0162-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
6 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1009222021:34 BUD: 03/21/2022; T1008022021:71 BUD: 01/29/2022; T1006072021:73 BUD: 12/04/2021

Recall Number: D-0198-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.25/PGE-1 6 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06162021:93 BUD: 10/23/2021

Recall Number: D-0109-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
15 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
CJC-1295 4MG/IPAMORELIN 4MG VIAL 4MG/4MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 05242021:73 BUD: 08/22/2021; 08032021:26 BUD: 11/01/2021; 06022021:49 BUD: 08/31/2021; 08122021:97 BUD: 11/10/2021

Recall Number: D-0156-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 0.75MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1008312021:33 BUD: 02/27/2022

Recall Number: D-0130-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
MIC B COMPLEX W CHROMIUM/ METHYLCOB (BOYDEN) INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09022021:50 BUD: 12/01/2021

Recall Number: D-0146-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRIMTROPIC - MIC B COMPLEX/CHROM/CARN 20MG/40MG/50MG/5MG/33MG/2MG/1MG/25MCG/25MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08062021:92 BUD: 02/02/2022

Recall Number: D-0178-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
334 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1006042021:60 BUD: 12/01/2021; T1008302021:63 BUD: 02/26/2022; T1005122021:36 BUD: 11/08/2021; T1007142021:23 BUD: 01/10/2022; T1008192021:94 BUD: 02/15/2022; 04202021:80 BUD: 10/17/2021; T1007012021:31 BUD: 12/28/2021; T1009092021:97 BUD: 03/08/2022; T1004092021:79 BUD: 10/06/2021; T1005242021:08 BUD: 11/20/2021; T1008092021:82 BUD: 02/05/2022; T1005042021:92 BUD: 10/31/2021; T1007262021:03 BUD: 01/22/2022; T1006172021:47 BUD: 12/14/2021

Recall Number: D-0224-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
3 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 6/PGE-1 60 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07142021:43 BUD: 10/23/2021

Recall Number: D-0215-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 60 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07222021:30 BUD: 11/30/2021

Recall Number: D-0149-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
23 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
VITAMIN D3 100,000 IU/ML INJECTABLE 100,000IU/ML, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 05272021:20 BUD: 11/23/2021; 06142021:34 BUD: 12/11/2021; 08052021:18 BUD: 01/05/2022; 08192021:43 BUD: 01/05/2022; 03302021:15 BUD: 08/12/2021

Recall Number: D-0169-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
168 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 100MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T0204272021:49 BUD: 10/24/2021; T0206142021:55 BUD: 12/11/2021; T0209082021:74 BUD: 03/07/2022; T0506212021:52 BUD: 12/18/2021; T0207082021:41 BUD: 01/04/2022; T0208112021:07 BUD: 02/07/2022; T0206012021:26 BUD: 11/28/2021; T0507122021:00 BUD: 01/08/2022; T0505112021:58 BUD: 11/07/2021; T0205182021:56 BUD: 11/14/2021; T0506102021:88 BUD: 12/07/2021; T0508182021:56 BUD: 02/14/2022

Recall Number: D-0157-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 1.5MG/DUTASTERIDE 1.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1009092021:66 BUD: 03/08/2022

Recall Number: D-0190-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 17.65/PHENTOLAMINE 0.59/PGE-1 5.9 INJ **T 101** INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07262021:32 BUD: 11/30/2021

Recall Number: D-0131-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
6 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
MIC B COMPLEX WITH HYDROXOCOBALAMIN 5MG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07152021:91 BUD: 10/13/2021; 08202021:06 BUD: 11/18/2021

Recall Number: D-0218-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 40 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 05142021:17 BUD: 10/23/2021; 08062021:79 BUD: 02/02/2022

Recall Number: D-0193-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 20/PHENTOLAMINE 1/PGE-1 20 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07282021:66 BUD: 11/30/2021

Recall Number: D-0158-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 1.5MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1009092021:19 BUD: 03/08/2022

Recall Number: D-0222-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
3 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 60 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07062021:22 BUD: 10/23/2021; 08262021:81 BUD: 02/22/2022

Recall Number: D-0187-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 15/PHENTOLAMINE 0.5/PGE-1 5 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07292021:21 BUD: 11/30/2021

Recall Number: D-0101-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
3 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ALPROSTADIL 25MCG/ML 25MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 04232021:91 BUD: 10/20/2021; 08022021:76 BUD: 11/30/2021

Recall Number: D-0106-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
B COMPLEX INJ CMP-NO B12, NO LIDOCAINE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07192021:91 BUD: 10/17/2021

Recall Number: D-0118-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
HYDROXOCOBALAMIN 5,000MCG/ML INJ 5,000MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08242021:51 BUD: 10/23/2021

Recall Number: D-0098-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
(WELL'S LIPO-LEAN)INOSITOL/CHOLINE/B-COMP+LEUCINE+CARN+ CHROM+LIDO 25MG/25MG/1.5MG/25MG/25MCG/10MG INJECTABLE in vials, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08062021:30 BUD: 10/31/2021

Recall Number: D-0184-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
40 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 50MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T0207282021:32 BUD: 11/20/2021; T0508162021:62 BUD: 02/12/2022; T0505242021:00 BUD: 11/20/2021; T0207232021:23 BUD: 11/20/2021

Recall Number: D-0152-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 0.75MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1005192021:31 BUD: 11/15/2021

Recall Number: D-0139-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
QUAD-MIX PAPAV 30/PHENTOL 2/PGE-1 200/ATROPINE 0.02 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 0802021:26 BUD: 11/30/2021

Recall Number: D-0111-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ESTRADIOL VALERATE 30MG/ML INJ #1 IN ETHYL OLEATE OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 04262021:43 BUD: 10/23/2021

Recall Number: D-0150-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 0.25MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1006032021:64 BUD: 11/30/2021

Recall Number: D-0196-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 25MG/PHENTOLAMINE 1MG/PGE1 25MCG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08312021:13 BUD: 02/08/2022

Recall Number: D-0128-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
MIC 20/40/50 /B COMPLEX +CHROM/CARN 25/25MG/ML+LIDO 20/40/50/25/25MG/ML+LIDO INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07292021:73 BUD: 10/30/2021

Recall Number: D-0105-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ALPROSTADIL 45MCG/ML 45MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06112021:61 BUD: 10/09/2021

Recall Number: D-0188-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 15/PHENTOLAMINE 1/PGE-1 10 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09082021:40 BUD: 02/08/2022

Recall Number: D-0189-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 15/PHENTOLAMINE 2/PGE-1 20 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09132021:55 BUD: 02/08/2022

Recall Number: D-0151-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
23 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07292021:54 BUD: 01/25/2022; T1006302021:96 BUD: 12/27/2021; T1008092021:60 BUD: 02/05/2022; T1009222021:51 BUD: 03/21/2022; T1006082021:79 BUD: 12/05/2021; T1008302021:82 BUD: 02/26/2022

Recall Number: D-0223-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 7.5/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06012021:18 BUD: 10/23/2021

Recall Number: D-0192-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 18/PHENTOL 0.6/PGE-1 6/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08062021:09 BUD: 11/30/2021

Recall Number: D-0216-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 100 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06212021:35 BUD: 10/23/2021

Recall Number: D-0136-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
QUAD-MIX PAPAV 30/PHENTOL 1/PGE-1 10/ATROPINE 0.15 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07072021:20 BUD: 10/23/2021

Recall Number: D-0108-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
8 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
BLUE TREE LIPO EXTREME (/W METHYLCOBALAMIN) INJECTION INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09172021:87 BUD: 12/16/2021

Recall Number: D-0209-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 40 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07272021:15 BUD: 11/30/2021; 07122021:11 BUD: 10/23/2021

Recall Number: D-0182-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
16 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 25MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T0508192021:06 BUD: 02/15/2022; T0507022021:91 BUD: 12/29/2021; T0507192021:13 BUD: 01/15/2022; T0504262021:71 BUD: 10/23/2021; T0509172021:03 BUD: 03/16/2022

Recall Number: D-0183-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 30MG/ML #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T0504202021:26 BUD: 10/17/2021

Recall Number: D-0172-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
9 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.5MG/ML INJ #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1004132021:95 BUD: 10/10/2021; T1006162021:63 BUD: 12/13/2021; T1004282021:19 BUD: 10/25/2021

Recall Number: D-0163-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 2MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1006032021:45 BUD: 11/30/2021

Recall Number: D-0137-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
QUAD-MIX PAPAV 30/PHENTOL 1/PGE-1 20/ATROPINE 0.1 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08052021:10 BUD: 11/30/2021

Recall Number: D-0141-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
QUAD-MIX PAPAV 30/PHENTOL 3/PGE-1 100/ATROPINE 0.2 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07162021:24 BUD: 11/13/2021

Recall Number: D-0185-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAV 23.3MG/PHENTOL 1MG/PGE-1 12MCG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07092021:15 BUD: 10/23/2021; 08182021:65 BUD: 02/08/2022

Recall Number: D-0165-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
21 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1006042021:53 BUD: 12/01/2021; T1008192021:83 BUD: 02/15/2022; T1005212021:52 BUD: 11/17/2021; T1009072021:35 BUD: 03/06/2022; T1007132021:61 BUD: 01/09/2022; T1009142021:95 BUD: 03/13/2022

Recall Number: D-0195-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 25/PHENTOLAMINE 3/PGE-1 80 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08042021:05 BUD: 11/30/2021

Recall Number: D-0164-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 2MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1007142021:50 BUD: 01/10/2022

Recall Number: D-0167-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1007222021:38 BUD: 01/18/2022

Recall Number: D-0212-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
7 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 30 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06252021:81 BUD: 10/23/2021; 09102021:09 BUD: 02/08/2022

Recall Number: D-0180-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
43 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ML INJ #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1007082021:20 BUD: 01/04/2022; T0907262021:21 BUD: 01/04/2022; T0506142021:81 BUD: 12/11/2021; T104142021:49 BUD: 10/11/2021; T1006022021:96 BUD: 11/29/2021; T0507152021:79 BUD: 01/11/2022; T1009082021:42 BUD: 03/07/2022; T0508172021:37 BUD: 02/13/2022; T0505112021:57 BUD: 10/11/2021

Recall Number: D-0119-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
IC B COMPLEX INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09152021:12 BUD: 12/14/2021

Recall Number: D-0140-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
3 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
QUAD-MIX PAPAV 30/PHENTOL 2/PGE-1 30/ATROPINE 0.2 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08182021:31 BUD: 02/08/2022; 08262021:69 BUD: 02/08/2022; 08052021:40 BUD: 11/30/2021

Recall Number: D-0134-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
PROGESTERONE 100MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07192021:31 BUD: 10/17/2021

Recall Number: D-0138-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
3 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
QUAD-MIX PAPAV 30/PHENTOL 2/PGE-1 20/ATROPINE 0.2 INJ *C5* INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06292021:27 BUD: 10/23/2021

Recall Number: D-0221-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 5 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 05192021:49 BUD: 10/23/2021

Recall Number: D-0176-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.75MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1007132021:95 BUD: 01/09/2022

Recall Number: D-0177-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
6 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1004202021:52 BUD: 10/17/2021; T1005042021:24 BUD: 10/31/2021

Recall Number: D-0123-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
5 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
LEUCINE 10MG/ ISOLEUCINE 15MG/ VALINE 40MG/ML (BCAA) INJ 10MG/15MG/40MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 05072021:81 BUD: 11/03/2021; 08122021:08 BUD: 02/08/2022

Recall Number: D-0219-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 40 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 05142021:17 BUD: 10/23/2021; 08062021:79 BUD: 02/02/2022

Recall Number: D-0168-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE BI-BLEND 100/100MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T7.803162021:08 BUD: 09/12/2021; TBB07142021:68 BUD: 01/10/2022

Recall Number: D-0147-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-TEST 200 (CY50%-EN37.5%-PR12.5%) INJ #1 200MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1007302021:37 BUD: 01/26/2022; T1008242021:04 BUD: 02/20/2022

Recall Number: D-0159-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
13 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 0.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1007072021:98 BUD: 01/03/2022; T1005252021:31 BUD: 11/21/2021; T1009222021:60 BUD: 03/21/2022

Recall Number: D-0132-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
MIC B12 25/50/50/0.5MG/ML L-CARNITINE 250MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07272021:62 BUD: 10/25/2021

Recall Number: D-0100-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ALPROSTADIL 22MCG/ML 22MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06082021:61 BUD: 10/06/2021

Recall Number: D-0200-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
5 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 20 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07142021:10 BUD: 10/23/2021; 08162021:23 BUD: 02/08/2022

Recall Number: D-0110-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ESTRADIOL VALERATE 10MG/ML IN ETHYL OLEATE 10MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06232021:55 BUD: 12/20/2021

Recall Number: D-0129-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
MIC B COMPLEX INJ-MILES FORMULATION INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08112021:46 BUD: 11/09/2021

Recall Number: D-0220-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
13 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 20 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06232021:24 BUD: 10/23/2021; 07192021:69 BUD: 01/15/2022; 09132021:87 BUD: 03/12/2022; 07282021:91 BUD: 01/24/2022; 04162021:06 BUD: 10/13/2021

Recall Number: D-0143-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
6 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
SERMORELIN ACETATE 15MG/IPAMORELIN 15MG - LYOPHILIZED 15MG/15MG VIAL, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07062021:98 BUD: 11/30/2021

Recall Number: D-0161-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
19 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1005172021:27 BUD: 11/13/2021; T1007222021:42 BUD: 01/18/2022; T1009162021:45 BUD: 03/15/2022

Recall Number: D-0102-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
3 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ALPROSTADIL 30MCG/ML INJ 30MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06142021:35 BUD: 10/23/2021; 07282021:49 BUD: 01/24/2022; 08302021:48 BUD: 02/26/2022

Recall Number: D-0103-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ALPROSTADIL 32MCG/ML 32MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08262021:68 BUD: 12/24/2021

Recall Number: D-0204-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
13 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 12 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07092021:34 BUD: 10/23/2021; 08302021:33 BUD: 02/08/2022; 08162021:08 BUD: 02/08/2022; 08262021:31 BUD: 02/08/2022; 09152021:63 BUD: 02/08/2022

Recall Number: D-0133-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
MIC B12 25/50/50/1+B6 100 MG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08112021:23 BUD: 11/09/2021

Recall Number: D-0113-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
15 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ESTRADIOL VALERATE 50MG/ML IN ETHYL OLEATE INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09162021:29 BUD: 03/15/2022; 09132021:31 BUD: 03/12/2022

Recall Number: D-0203-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
3 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1.5/PGE-1 50 INJ **ST 1** INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07162021:14 BUD: 11/30/2021; 09142021:63 BUD: 02/08/2022

Recall Number: D-0197-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 26/PHENTOLAMINE 3/PGE-1 60/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08192021:32 BUD: 02/15/2022

Recall Number: D-0120-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
122 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
IVME HCG VITAMIN B INJ (CONTAINS NO HCG) INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09092021:04 BUD: 12/09/2021; 07262021:55 BUD: 10/24/2021

Recall Number: D-0145-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
3 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
SERMORELIN ACETATE 9MG/IPAMORELIN 9MG - LYOPHILIZED 9MG/9MG VIAL, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08102021:22 BUD: 11/30/2021

Recall Number: D-0225-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 40/PHENTOLAMINE 2/PGE-1 10 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 04222021:98 BUD: 10/19/2021

Recall Number: D-0160-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 1MG/DUTASTERIDE 1.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1009132021:38 BUD: 03/12/2022

Recall Number: D-0135-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
QUAD-MIX PAPAV 20/PHENTOL 2/PGE-1 25/ATROPINE 0.2 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08032021:56 BUD: 11/30/2021

Recall Number: D-0115-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
7 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ESTRADIOL VALERATE 5MG/ML IN ETHYL OLEATE 5MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07232021:10 BUD: 01/19/2022; 04162021:56 BUD: 10/13/2021; 08172021:62 BUD: 02/13/2022; 05272021:21 BUD: 11/23/2021

Recall Number: D-0122-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
L-CARNITINE 250MG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08172021:31 BUD: 11/15/2021; 07152021:16 BUD: 10/13/2021

Recall Number: D-0217-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
3 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 30 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06282021:57 BUD: 10/23/2021

Recall Number: D-0213-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
8 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 40 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06232021:01 BUD: 10/23/2021; 08132021:58 BUD: 02/08/2022

Recall Number: D-0206-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
22 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 20 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07142021:91 BUD: 10/23/2021; 08122021:46 BUD: 02/08/2022; 07092021:88 BUD: 10/23/2021; 08022021:45 BUD: 11/30/2021; 09082021:46 BUD: 02/08/2022

Recall Number: D-0166-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
6 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1008312021:02 BUD: 02/27/2022; T1007142021:62 BUD: 01/10/2022

Recall Number: D-0127-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
MIC 20/40/50 /B COMPLEX +CHROM/CARN 25/25MG/ML 20/40/50/25/25MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08172021:52 BUD: 02/13/2022

Recall Number: D-0116-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
5 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
GOAL-GLUTAMINE 75MG/ORNITHINE 75MG/ARGININE 150MG/LYSINE 150MG+LIDOCAINE 10MG/ML 75MG/75MG/150MG/150MG/10MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 05062021:44 BUD: 11/02/2021; 08192021:87 BUD: 02/15/2022

Recall Number: D-0144-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
11 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
SERMORELIN ACETATE 6MG/IPAMORELIN 6MG - LYOPHILIZED 6MG/6MG VIAL, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06022021:03 BUD: 11/29/2021; 08102021:27 BUD: 11/30/2021; 05212021:84 BUD: 11/17/2021

Recall Number: D-0226-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 40/PHENTOLAMINE 2/PGE-1 40 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07192021:30 BUD: 01/15/2022

Recall Number: D-0210-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 5 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08042021:56 BUD: 11/30/2021

Recall Number: D-0117-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
HYDROXOCOBALAMIN 1,000MCG/ML INJ VIAL 1,000MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09102021:19 BUD: 11/09/2021

Recall Number: D-0171-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
94 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.5MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1005122021:40 BUD: 11/08/2021; T1006092021:88 BUD: 12/06/2021; T1008242021:26 BUD: 02/20/2022; T1007192021:94 BUD: 01/15/2022

Recall Number: D-0153-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 1.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1007012021:96 BUD: 12/28/2021; T1008192021:04 BUD: 02/15/2022

Recall Number: D-0201-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 30 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06252021:22 BUD: 10/23/2021

Recall Number: D-0211-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
22 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 20 INJ **T 104** INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07192021:23 BUD: 01/15/2022; 08032021:21 BUD: 01/30/2022; 04282021:39 BUD: 10/23/2022; 06102021:69 BUD: 10/23/2021

Recall Number: D-0097-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
335 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
Estradiol Valerate 20 mg/mL in Ethyl Oleate Inj. 20 mg/mL Injection in vials, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 04122021:51 BUD: 10/09/2021; 04232021:94 BUD: 10/20/2021; 05032021:52 BUD: 10/30/2021; 05242021:73 BUD: 11/20/2021; 05172021:47 BUD: 11/13/2021; 06302021:93 BUD: 12/27/2021; 06222021:98 BUD: 12/19/2021; 06072021:83 BUD: 12/04/2021; 07152021:86 BUD: 01/11/2022; 07222021:52 BUD: 01/18/2022; 08062021:11 BUD: 02/02/2022; 08192021:73 BUD: 02/15/2022; 08312021:22 BUD: 02/27/2022; 09162021:58 03/15/2022; 09082021:15 BUD: 03/07/2022

Recall Number: D-0207-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 25 INJ**T 106** INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07232021:18 BUD: 11/30/2021

Recall Number: D-0155-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
50 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 1MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1008192021:69 BUD: 02/15/2022; T1006142021:66 BUD: 12/11/2021; T1009092021:76 BUD: 03/08/2022; T1005142021:82 BUD: 11/10/2021; T1009212021:33 BUD: 03/20/2022; T1006012021:01 BUD: 11/28/2021

Recall Number: D-0114-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ESTRADIOL VALERATE 50MG/ML INJ #2 INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09162021:22 BUD: 03/15/2022

Recall Number: D-0174-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.7MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1007202021:25 BUD: 01/16/2022; T1009102021:46 BUD: 03/09/2022

Recall Number: D-0199-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 10 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06252021:39 BUD: 10/23/2021; 08132021:31 BUD: 02/08/2022

Recall Number: D-0124-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
696 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
MEDROXYPROGESTERONE ACET 150MG/ML SUSP (PF) 150MG/ML SUSPENSION, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07222021:40 BUD: 10/20/2021; 03302021:60 BUD: 10/26/2021; 04122021:29 BUD: 11/08/2021; 08172021:38 BUD: 11/15/2021; 07072021:60 BUD: 10/05/2021

Recall Number: D-0186-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
24 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 15/PHENTOLAMINE 0.25/PGE-1 6 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot:08192021:49 BUD: 02/08/2022; 08102021:33 BUD: 11/30/2021; 06302021:75 BUD: 10/23/2021; 09032021:05 BUD: 02/08/2022

Recall Number: D-0125-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
324 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
METHYLCOBALAMIN 1MG/ML (1000MCG/ML) INJ 1MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07292021:79 BUD: 10/27/2021; 09072021:33 BUD: 12/07/2021; 09072021:32 BUD: 12/07/2021; 08312021:30 BUD: 11/29/2021; 07222021:66 BUD: 10/20/2021; 08242021:10 BUD: 11/22/2021; 07262021:12 BUD: 10/24/2021; 08182021:08 BUD: 11/16/2021; 09072021:31 BUD: 12/07/2021; 09092021:32 BUD: 12/08/2021; 09212021:12 BUD: 12/20/2021; 09212021:88 BUD: 12/20/2021.

Recall Number: D-0112-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
11 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ESTRADIOL VALERATE 40MG/ML IN ETHYL OLEATE INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 09082021:11 BUD: 03/07/2022; 07022021:66 BUD: 12/29/2021; 05202021:46 BUD: 11/16/2021; 08192021:24 BUD: 02/15/2022

Recall Number: D-0148-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
23 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ULTRA-TEST (CYP 80%/PROP 20%) 200MG/ML INJ #1 200MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1008032021:86 BUD: 01/30/2022; T1004192021:25 BUD: 10/16/2021; T1005252021:33 BUD: 11/21/2021; T1009082021:96 BUD: 03/07/2022

Recall Number: D-0191-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
2 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 18/PHENTOL 0.6/PGE-1 5.88/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08062021:45 BUD: 11/30/2021; 07132021:75 BUD: 10/23/2021

Recall Number: D-0175-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
6 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.5MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1009092021:50 BUD: 03/08/2022; T1006302021:37 BUD: 12/27/2021

Recall Number: D-0142-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
QUAD-MIX PAPAV 30/PHENTOL 4/PGE-1 40/ATROPINE 0.4 INJ *C6* INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07192021:52 BUD: 11/30/2021

Recall Number: D-0202-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 40 /ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08092021:52 BUD: 11/30/2021

Recall Number: D-0107-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
BI-MIX PAPAVERINE 40/PHENTOLAMINE 2 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08182021:00 BUD: 12/16/2021

Recall Number: D-0194-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 23.3/PHENTOLAMINE 1/PGE-1 12 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08102021:71 BUD: 11/30/2021

Recall Number: D-0099-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
ALPROSTADIL 22.5MCG/ML 22.5MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 08022021:14 BUD: 11/30/2021

Recall Number: D-0154-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 1MG/ML #2 INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1008252021:29 BUD: 02/21/2022; T1006042021:51 BUD: 12/01/2021

Recall Number: D-0173-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.75MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T1008032021:52 BUD: 01/30/2022; T1008192021:96 BUD: 02/15/2022

Recall Number: D-0214-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
4 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 50 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07082021:16 BUD: 10/23/2021; 08172021:26 BUD: 02/08/2022

Recall Number: D-0121-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
99 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
IVME SUPER B INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07262021:54 BUD: 10/24/2021; 07262021:04 BUD: 10/24/2021; 09092021:07 BUD: 12/09/2021; 09092021:97 BUD: 12/09/2021; 09102021:10 BUD: 12/09/2021

Recall Number: D-0181-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
7 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TESTOSTERONE CYPIONATE 20MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: T0507152021:64 BUD: 01/11/2022; T0507232021:35 BUD: 01/19/2022; T0507292021:15 BUD: 01/25/2022

Recall Number: D-0205-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
30 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 2.5 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07222021:11 BUD: 11/30/2021; 08172021:72 BUD: 02/08/2022; 06282021:84 BUD: 10/23/2021; 07132021:93 BUD: 10/23/2021; 09102021:43 BUD: 02/08/2022

Recall Number: D-0208-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
5 vials

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 30 INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 06252021:69 BUD: 10/23/2021; 08272021:62 BUD: 02/08/2022

Recall Number: D-0126-2022

Reason for Recall
Lack of assurance of sterility
Initiated
10-12-2021
Reported
11-17-2021
Quantity
1 vial

Recall Profile & Regulatory Data

Event ID About Event ID
Numerical designation assigned by FDA to a specific recall event.
88862
Classification About Classification
Relative degree of health hazard assigned by FDA.
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Product Type About Product Type
Broad category of product being recalled.
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Telephone
Distribution Pattern About Distribution Pattern
General area of initial distribution.
United States including Washington, D.C. and Puerto Rico
Termination Date About Termination Date
Date that FDA officially terminated the recall.
10-04-2023
Product Description About Product Description
Full technical description of the product.
METHYLCOBALAMIN 5MG/ML (5000MCG/ML) INJ 5MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Batch or Lot Expiration Information

Lot# Lot: 07162021:70 BUD: 10/14/2021